Sort   by:  
 Page size 
ProteomicsChemical crosslinking and mass spectrometry of the human Rix1 complex
PELP1 is a scaffold protein with diverse cellular functions including its role as the central scaffold for the human Rix1 complex (PELP1, WDR18, TEX10, and SENP3). We have reconstituted the mammalian Rix1 complex and identified a sub-complex made of the conserved Rix1 domain of PELP1 and the WDR18 p...
ORGANISM(S): Homo sapiens (Human) 
2023-03-11 | PXD037729 | Pride
Q-exactive Lc-ms Rix1 Protein prospector Pelp1 Bs3 Crosslinking 
UnknownThe 2021 update of the EPA's adverse outcome pathway database.
Not available
S-EPMC8275694 | biostudies-literature
UnknownA harmonized chemical monitoring database for support of exposure assessments.
Not available
S-EPMC9203490 | biostudies-literature
UnknownCryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold.
Not available
S-EPMC9646879 | biostudies-literature
UnknownEvidence for Cross Species Extrapolation of Mammalian-Based High-Throughput Screening Assay Results.
Not available
S-EPMC8283686 | biostudies-literature
UnknownThe TRIM-NHL RNA-binding protein Brain Tumor coordinately regulates expression of the glycolytic pathway and vacuolar ATPase complex.
Not available
S-EPMC11551770 | biostudies-literature
MetabolomicsELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with distinct molecular subtypes described as classical/progenitor and basal-like/squamous PDAC. We hypothesized that integrative transcriptome and metabolome approaches can identify candidate genes whose inactivation contributes to ...
2024-04-02 | MTBLS9418 | MetaboLights
UnknownDefining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.
Not available
S-EPMC10165617 | biostudies-literature
UnknownIntimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial.
Not available
S-EPMC10148927 | biostudies-literature
UnknownPrespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Not available
S-EPMC4898313 | biostudies-literature
Sort   by:  
 Page size